Betnovate Lotion (PGD) 100ml
Betnovate Lotion (PGD) 100ml
Betnovate Lotion is a renowned treatment option known for its efficacy in alleviating severe atopic eczema. Unlike other products on the market, this lotion offers a unique formulation infused with betamethasone valerate, providing targeted relief from inflammation and itching.
Accessible privately after a simple consultation with a pharmacist, Betnovate Lotion grants individuals the power to take control of their skin health without the usual complications of booking an appointment with a GP. Its smooth, easy-to-apply texture ensures a hassle-free application process that leads to visible results.
To ensure suitability and optimal results, interested individuals are encouraged to consult with our professional pharmacist who can guide them in making an informed purchase decision.
- Effective Formulation: Contains betamethasone valerate, a potent corticosteroid, for rapid relief from inflammation and itching.
- Private Access: Available privately after a consultation with a pharmacist, bypassing usual prescription constraints.
- Easy Application: Smooth texture ensures a simple and hassle-free application process ideal for hairy or large areas;
- Promotes Skin Health: Addresses not only symptoms but also underlying causes to promote long-term skin wellbeing.
- Professional Guidance: Tailored advice and guidance available from our professional pharmacists to ensure suitability and optimal results.
Frequently Asked Questions (FAQs):
Is this an over-the-counter medication?
No, this is a prescription-only-medication that can be purchased over the counter via a private service called PGD (Patient Group Direction).
What will happen once I have answered the questions in the form?
A pharmacist trained to provide this private service will assess the form and call you to discuss the answers you provided with you.
Why do I need to provide my phone number?
In order to dispense this medication without a prescription, the consultation must be carried out via phone or video call. As well as this being a legal requirement to ensure that the medication is suitable for you, the final phone consultation will allow you to ask any questions you may have to the pharmacist.
Is the consultation private?
Patient confidentiality is one of our top priorities, both the form you fill and the phone consultation are strictly confidential between you and the pharmacist.
Do I need to pay for the consultation?
The price you see is inclusive of the consultation fee, so you will not have to pay anything extra.
Active ingredients: Betamethasone Valerate 0.122% w/w
Other ingredients: Methyl Hydroxybenzoate, Xanthan Gum, Cetostearyl Alcohol, Liquid Paraffin, Isopropyl Alcohol, Glycerol, Macrogol cetostearyl ether, Sodium citrate, Citric Acid Monohydrate, Purified Water
Usage and Instructions
Apply once or twice daily for up to 4 weeks until improvement occurs, then reduce the frequency of application or change the treatment to a less potent preparation.
Apply thinly and gently rub in using only enough to cover the entire affected area. Allow adequate time for absorption after each application before applying an emollient.
Local Hypersensitivity: Patients with a prior history of sensitivity to corticosteroids should exercise caution when using Betamethasone valerate. The symptoms of local allergic reactions may mimic those of the condition being treated.
Potential Side Effects: In some individuals, overuse of topical steroids like Betamethasone valerate can lead to hypercortisolism (Cushing's syndrome) and reversible disruption of the HPA axis, causing a deficiency in glucocorticosteroids. If these issues arise, reduce the application frequency or switch to a milder steroid. Suddenly stopping the treatment might result in glucocorticosteroid insufficiency.
Risk Factors for Systemic Effects:
- Potency and makeup of the topical steroid
- Length of exposure
- Applying to extensive skin areas
- Enhanced hydration of skin's surface layer
- Use on sealed, thin, or broken skin
- Children may be more at risk due to immature skin and greater surface area relative to body weight
Paediatric Considerations: For children under 12, limit treatment to five days, avoid occlusions, and use long-term corticosteroid therapy sparingly, as it can suppress the adrenal gland.
Infection Risk with Sealing Treatments: Occlusive dressings or skin folds can encourage bacterial infections. Cleanse the skin before applying a new dressing.
Use in Psoriasis: Exercise caution with psoriasis due to potential risks like rebound relapses and tolerance. Close monitoring is essential.
Visual Disturbances: Blurred vision or other visual problems may occur with corticosteroids. Consider referral to an eye specialist if these symptoms present, as they could be signs of cataract, glaucoma, or rare diseases like CSCR.
Scalp Application Instructions: Patients must:
- Keep the product away from the eyes
- Refrain from smoking while using Betnovate scalp application
- Avoid exposure to fire, flame, or heat, including hair dryers, after application
These guidelines ensure safe and effective use of Betnovate scalp application, accommodating various individual needs and potential risks.
|Category||Frequency||Condition or Symptom|
|Infections and Infestations||Very rare||Opportunistic infection|
|Immune System Disorders||Very rare||Hypersensitivity, generalised rash|
|Endocrine Disorders||Very rare||Hypothalamic-pituitary adrenal (HPA) axis suppression, Cushingoid features (e.g. moon face, central obesity), delayed weight gain/growth retardation in children, osteoporosis, glaucoma, hyperglycaemia/glucosuria, cataract, hypertension, increased weight/obesity, decreased endogenous cortisol levels, alopecia, trichorrhexis|
|Skin and Subcutaneous Tissue Disorders||Common||Pruritus, local skin burning /skin pain|
|Very rare||Allergic contact dermatitis /dermatitis, erythema, rash, urticaria, pustular psoriasis, skin thinning / skin atrophy, skin wrinkling, skin dryness, striae, telangiectasias, pigmentation changes*, hypertrichosis, exacerbation of underlying symptoms|
|General Disorders and Administration Site Conditions||Very rare||Application site irritation/pain|
|Eye disorders||Not known||Vision, blurred (see also section 4.4)|
*Skin features secondary to local and/or systemic effects of hypothalamic-pituitary adrenal (HPA) axis suppression.